Rehabilitation program to improve walking in patients with lumbar spinal stenosis
Effectiveness of a 6-week Specific Rehabilitation Program Combining Education and Exercises on Walking Capacity in Patients with Lumbar Spinal Stenosis with Neurogenic Claudication
NA · Université du Québec à Trois-Rivières · NCT05513326
This study tests if a 6-week rehab program that includes exercises can help people with lumbar spinal stenosis walk better compared to just getting education.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Université du Québec à Trois-Rivières (other) |
| Locations | 1 site (Trois-Rivières, Quebec) |
| Trial ID | NCT05513326 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a 6-week rehabilitation program that combines education and specific exercises for patients suffering from lumbar spinal stenosis and neurogenic claudication. Participants in the intervention group will receive both education and exercises, while the control group will only receive education. The program will include four evaluation timepoints to assess walking capacity and other related outcomes such as pain intensity and disability. The primary measure of effectiveness will be the Self-Paced Walking Test.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50 and older with degenerative lumbar spinal stenosis and neurogenic claudication who can walk at least 20 meters without assistance.
Not a fit: Patients with congenital lumbar spinal stenosis, significant osteoarthritis, or neurological diseases affecting walking capacity may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance walking capacity and overall quality of life for patients with lumbar spinal stenosis.
How similar studies have performed: Other studies have shown positive outcomes with rehabilitation programs for similar conditions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * being at least 50 years old * having a degenerative central LSS alone or in combination with other LSS types (e.g. foraminal, lateral) and/or a spondylolisthesis affecting one or multiple vertebral levels, confirmed by clinical history, physical examination and proper imaging * having NC associated with LSS * being able to speak and understand French * being willing to attend 3 intervention sessions per week * with a duration of signs and symptoms of at least 3 months * (7) being able to walk at least 20 meters without walking aid, but not being able to walk continuously for 30 minutes * being able to provide informed written consent. Exclusion Criteria: * congenital LSS, * symptomatic osteoarthritis (hip or knee) causing limited walking capacity * neurological disease affecting walking capacity such as Parkinson * uncontrolled diabetes * heart failure * intermittent claudication of vascular origin * impaired cognitive capacity * back or lower extremities surgery in the past 3 months
Where this trial is running
Trois-Rivières, Quebec
- Université du Québec à Trois-Rivières — Trois-Rivières, Quebec, Canada (RECRUITING)
Study contacts
- Study coordinator: Mariève Houle, PhD(c)
- Email: marieve.houle@uqtr.ca
- Phone: 819 376-5011
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Spinal Stenosis, Neurogenic claudication, Walking capacity, Exercises, Education, gait pattern characteristics